Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | DGKA | P23743 | 1/20 | 0.47 |
| ▸ | PAM | P19021 | 2/20 | 0.44 |
| ▸ | TSHR | P16473 | 1/20 | 0.41 |
| ▸ | MAPT | P10636 | 1/20 | 0.41 |
| ▸ | FAAH | O00519 | 6/20 | 0.41 |
| ▸ | LMNA | P02545 | 2/20 | 0.41 |
| ▸ | DNM1 | Q05193 | 1/20 | 0.41 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.41 |
| ▸ | CES1 | P23141 | 4/20 | 0.40 |
| ▸ | MEN1 | O00255 | 2/20 | 0.40 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.40 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.40 |
| ▸ | DUSP3 | P51452 | 1/20 | 0.40 |
| ▸ | CES2 | O00748 | 1/20 | 0.40 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.40 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL11917857 | 0.95 | DGKA (0.41) | DGKAPAMTSHRMAPTFAAH | |
| SCHEMBL11917851 | 0.89 | ALDH1A1 (0.38) | DGKALMNAALDH1A1 | |
| SCHEMBL3430825 | 0.84 | DGKA (0.50) | DGKAPAMTSHRMAPTFAAH | |
| SCHEMBL18785733 | 0.83 | DGKA (0.53) | DGKAPAMTSHRMAPTFAAH | |
| SCHEMBL18785847 | 0.83 | DGKA (0.53) | DGKAPAMTSHRMAPTFAAH | |
| SCHEMBL18785845 | 0.83 | DGKA (0.53) | DGKAPAMTSHRMAPTFAAH | |
| SCHEMBL18785736 | 0.83 | DGKA (0.53) | DGKAPAMTSHRMAPTFAAH | |
| SCHEMBL11917862 | 0.83 | DGKA (0.53) | DGKAPAMTSHRMAPTFAAH | |
| SCHEMBL18785735 | 0.83 | DGKA (0.53) | DGKAPAMTSHRMAPTFAAH | |
| SCHEMBL18785732 | 0.83 | DGKA (0.53) | DGKAPAMTSHRMAPTFAAH |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8853441-B2 | Sulfonium compound, photoacid generator, and resist composition | KOREA KUMHO PETROCHEMICAL CO., LTD. (KR) | 2014-10-07 | — | — | US | disclosed |
| US-20130035503-A1 | SULFONIUM COMPOUND, PHOTOACID GENERATOR, AND RESIST COMPOSITION | KOREA KUMHO PETROCHEMICAL CO., LTD. (KR) | 2013-02-07 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20130035503-A1 | SULFONIUM COMPOUND, PHOTOACID GENERATOR, AND RESIST COMPOSITION | SRP54, SRSF1, SRSF7 | DGKA 2875/4885PAM 606/4885TSHR 1645/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.